Individual Applicant
--------------------
      Street : 
      City : 
      State : 
      Country : 
      PostalCode : 
      PhoneNumber : 
      FaxNumber : 
      EmailAddress : 
<110> LastName : Wang
<110> FirstName : Tianxin
<110> MiddleInitial : 
<110> Suffix : 

Application Project
-------------------
<120> Title : Methods for protein modification in pharmaceutical applications
<130> AppFileReference : 001
<140> CurrentAppNumber : 
<141> CurrentFilingDate : ____-__-__

Earlier Applications
--------------------
<150> PriorAppNumber : US 62/174,528 
<151> PriorFilingDate : 2015-06-12

Sequence
--------
<213> OrganismName : affinity peptide
<400> PreSequenceString : 
NIYNCEPANP SEKNSPSTQY CYSI                                               24
<212> Type : PRT
<211> Length : 24
      SequenceName : affinity peptide
      SequenceDescription : 

Sequence
--------
<213> OrganismName : affinity peptide
<400> PreSequenceString : 
LLGPYELWEL SHGGSGGSGG SGGSVPLSLY SGGSGGSGGS                              40
<212> Type : PRT
<211> Length : 40
      SequenceName : affinity peptide 2
      SequenceDescription : 

Sequence
--------
<213> OrganismName : affinity apater
<400> PreSequenceString : 
cgagaggttg gtgtggttgg                                                    20
<212> Type : DNA/RNA
<211> Length : 20
      SequenceName : aptamer
      SequenceDescription : 

Sequence
--------
<213> OrganismName : linker peptide
<400> PreSequenceString : 
GGASEGSDEA EGSEASGEGD GASEGSDEAE GSEASGEGDG ASEGSDEAEG SEASGEGDGA        60SEGSDEAEGS EASGEGDGAS EGSDEAEGSE ASGEGDGGG                               99
<212> Type : PRT
<211> Length : 99
      SequenceName : peptide linker
      SequenceDescription : 

Sequence
--------
<213> OrganismName : linker peptide
<400> PreSequenceString : 
GGDGSEGSEG EASEGSAEGE GGSEGSEGEA SEGSAEGEGD GG                           42
<212> Type : PRT
<211> Length : 42
      SequenceName : peptide linker 2
      SequenceDescription : 

